Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/10/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Colin N. Scott

Wrong Dr. Colin N. Scott?

Senior Director Clinical Developm...

Phone: +44 *** *** ****  HQ Phone
Email: c***@***.uk
Local Address: New York City, New York, United States
Forest Research
Northern Research Station
Roslin, Midlothian EH25 9SY
United Kingdom

Company Description: Forest Research is committed to delivering high quality scientific research which fully meets our customers' needs for quality assurance. We aim to offer a flexible...   more
Background

Employment History

Education

  • M.D.
  • medical degree , pulmonology and infectious diseases
    Glasgow University
32 Total References
Web References
...
www.sec.gov, 1 Feb 2011 [cached]
0001410581 Scott Colin C/O NOVABAY PHARMACEUTICALS, INC. 5980 HORTON STREET, SUITE 550 EMERYVILLE CA 94608 1 VP, Clinical Research and Dev
Emisphere Technologies, Inc. - Emisphere Receives Patent Covering Oral Parathyroid Hormone Composition With Lilly
ir.emisphere.com [cached]
In addition, Emisphere also announced the appointment of Colin N. Scott, M.D., to the position of Vice President, Clinical Affairs.
Dr. Scott brings over 20 years of clinical program development expertise in a variety of therapeutic areas to Emisphere, and will be responsible for overseeing the development of all clinical programs to obtain and maintain product registrations, and for the clinical development of the Company's platform drug delivery technology. Dr. Scott's experience includes managing, executing and designing clinical trials in all phases of development through pre-launch.
Dr. Scott joins Emisphere from Muro/ASTA Medica, Inc., a wholly owned subsidiary of the Rx-Healthcare Division of ASTA Medica AG, headquartered in Frankfurt, Germany, where he held the position of Director, Medical Affairs. Previously, Dr. Scott was Vice President, Clinical and Regulatory Affairs at CytoMed, Inc. Dr. Scott received his medical degree from Glasgow University, Scotland.
...
We are pleased that Dr. Scott has joined at this exciting time, to lead our efforts as we expand and advance multiple products into the clinic this year. His clinical affairs expertise will also help to establish a long-term clinical development strategy for our earlier-stage product candidates. We look forward to Dr. Scott's participation in creating the clinical infrastructure necessary to capture the potential of Emisphere's product pipeline."
PharmaLive
www.medadnews.com, 14 June 2001 [cached]
In addition , Emisphere also announced the appointment of Colin N. Scott , M.D. , to the position of Vice President , Clinical Affairs.
Dr. Scott brings over 20 years of clinical program development expertise in a variety of therapeutic areas to Emisphere , and will be responsible for overseeing the development of all clinical programs to obtain and maintain product registrations , and for the clinical development of the Company's platform drug delivery technology.Dr. Scott's experience includes managing , executing and designing clinical trials in all phases of development through pre-launch.
Dr. Scott joins Emisphere from Muro/ASTA Medica , Inc. , a wholly owned subsidiary of the Rx-Healthcare Division of ASTA Medica AG , headquartered in Frankfurt , Germany , where he held the position of Director , Medical Affairs.Previously , Dr. Scott was Vice President , Clinical and Regulatory Affairs at CytoMed , Inc..Dr. Scott received his medical degree from Glasgow University , Scotland.
Colin Scott, M.B., Ch.B., ...
www.novabaypharma.com, 19 Nov 2008 [cached]
Colin Scott, M.B., Ch.B., Vice President, Clinical Research and Development
Colin Scott, M.B., Ch.B., has served as NovaBay's Vice President, Clinical Research and Development since January 2006. Prior to joining NovaBay, Dr. Scott was the Vice President, Drug Development for GlycoMimetics.
Dr. Scott has held senior management roles at Arriva Pharmaceuticals, Inc., and Emisphere Technologies, Inc.
Dr. Scott received a medical degree in pulmonology and infectious diseases from Glasgow University in Scotland.
Colin Scott, a speaker at the ...
www.marcusevans.com [cached]
Colin Scott, a speaker at the marcus evans Evolution Summit 2013, on conducting clinical trials in a new pharma landscape.
Interview with: Colin Scott, Senior director, Clinical Develop Respiratory, Forest Research Institute
...
This disconnect has to be addressed," says Colin Scott, Senior Director, Clinical Development Respiratory, Forest Research Institute.
Scott is a speaker at the upcoming marcus evans Evolution Summit 2013 in Palm Beach, Florida, May 8-10.
...
Colin Scott Interview
Other People with the name "Scott":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304